海尔生物与泰国RAM医疗集团达成战略合作，共创东南亚智慧医疗新模式

Core Insights - The collaboration between Haier Biomedical and RAM Medical Group marks a significant step in Haier's "one country, one policy" overseas strategy, focusing on technology solutions and localized services in Southeast Asia [1][5][6] - Southeast Asia, with its growing elderly population and economic development, presents a lucrative market for medical technology, particularly in Thailand, which has urgent needs for automation and smart medical devices [3][5] Group 1: Strategic Collaboration - Haier Biomedical has signed a strategic cooperation agreement with RAM Medical Group to implement pharmacy automation and smart medical solutions, enhancing healthcare efficiency and safety [4][6] - The partnership aims to create a comprehensive ecosystem by integrating customized products and localized operations, transitioning from merely selling products to providing services [5][6] Group 2: Market Potential - Southeast Asia's population of 670 million and over 10% growth in the elderly demographic make it a prime market for medical technology advancements [3][7] - The collaboration is expected to serve not only local Thai patients but also international medical tourists, thereby injecting efficiency and safety into regional healthcare services [4][6] Group 3: Technological Innovation - Haier Biomedical's approach emphasizes "customized technology + localized operations" to address the diverse needs of different medical markets, showcasing its capabilities in low-temperature storage and laboratory solutions [3][5] - The partnership will initially focus on pharmacy automation solutions, including outpatient pharmacy systems and smart inventory management, to streamline the drug distribution process [4][6] Group 4: Future Outlook - The collaboration is seen as a model for replicating successful strategies in other emerging markets, potentially expanding Haier Biomedical's influence in the global healthcare landscape [6][7] - As the partnership develops, RAM Medical Group plans to gradually adopt a full range of Haier Biomedical's products and solutions, indicating a shift from isolated projects to a comprehensive healthcare ecosystem [5][6]